These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2806012)

  • 1. [Effect of splenectomy on the growth of implanted hepatoma and peripheral T-cell subsets in the rat].
    Ge YG
    Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):305-8, 318-9. PubMed ID: 2806012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T cell subsets in peripheral blood and spleen in malignant hepatoma bearing rats].
    Ge YG
    Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):417-20. PubMed ID: 3266931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of splenectomy on the growth of W256 carcinosarcoma and T cell subsets of peripheral blood in rat].
    Ge YG
    Zhonghua Zhong Liu Za Zhi; 1989 Jan; 11(1):8-11. PubMed ID: 2528446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of T lymphocyte subsets in BERH-2 hepatoma-bearing rats and effect of different immunotherapies on the tumor].
    Guo YJ
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):168-71. PubMed ID: 2482158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of growth of metastases in rat liver by perioperative immunoactivation.
    Yamashita R; Hiraoka T; Kamimoto I; Miyauchi Y
    Cancer Res; 1986 Jun; 46(6):3138-41. PubMed ID: 3486044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of peripheral T-cell subsets in asplenic W256 tumor-bearing rats.
    Ge YG; Gao H; Kong XT
    J Surg Oncol; 1989 Sep; 42(1):60-8. PubMed ID: 2788779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits.
    Wissniowski TT; Hänsler J; Neureiter D; Frieser M; Schaber S; Esslinger B; Voll R; Strobel D; Hahn EG; Schuppan D
    Cancer Res; 2003 Oct; 63(19):6496-500. PubMed ID: 14559842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of biometric parameters of Morris hepatoma after application of human recombinant tumor necrosis factor.
    Terlikowski S; Nowak HF; Lotocki W
    Neoplasma; 1995; 42(2):83-7. PubMed ID: 7617082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal transplantation of Yoshida ascites hepatoma cells after fine needle aspiration from tumor bearing rats organs.
    Roveta G; Magrassi L
    Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1277-81. PubMed ID: 6477742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
    Mizejewski GJ; Macario AL
    Neoplasma; 1983; 30(1):23-34. PubMed ID: 6188067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in whole body, muscle, liver, and tumor tissue protein synthesis and degradation in Novikoff hepatoma and Yoshida sarcoma tumor growth studied in vivo.
    Tayek JA; Blackburn GL; Bistrian BR
    Cancer Res; 1988 Mar; 48(6):1554-8. PubMed ID: 3345528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of salicylamide on the growth of a Morris hepatoma in rats fed 8% and 25% casein diets.
    Knight EM; Nzelibe G; Criss W
    Drug Nutr Interact; 1983; 2(2):87-94. PubMed ID: 6678754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of energy metabolism in Morris hepatoma 7777 and 7800.
    Fields AL; Wolman SL; Cheema-Dhadli S; Morris HP; Halperin ML
    Cancer Res; 1981 Jul; 41(7):2762-6. PubMed ID: 7248942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of splenectomy on antitumor immune system in mice.
    Higashijima J; Shimada M; Chikakiyo M; Miyatani T; Yoshikawa K; Nishioka M; Iwata T; Kurita N
    Anticancer Res; 2009 Jan; 29(1):385-93. PubMed ID: 19331177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidisciplinary treatment of metastatic brain tumor and its fundamental studies for chemo-immunotherapy].
    Kobayashi T
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1022-9. PubMed ID: 6332206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and serological changes in the peripheral blood of splenectomized and spleen autotransplanted mice.
    Sipka S; Bráth E; Tóth FF; Aleksza M; Kulcsár A; Fábián A; Baráth S; Balogh P; Sipka S; Furka I; Mikó I
    Transpl Immunol; 2006 Aug; 16(2):99-104. PubMed ID: 16860712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-lymphocyte subsets in healthy splenectomised patients.
    Lauria F; Pulvirenti A; Raspadori D; Tura S
    Boll Ist Sieroter Milan; 1981 Nov; 60(5):417-20. PubMed ID: 6978724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Splenocyte functional activity in mice growing the syngeneic transplantable hepatoma 22a].
    Kiseleva EP; Malygin AM
    Tsitologiia; 1984 Dec; 26(12):1409-15. PubMed ID: 6335612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.
    Man K; Ng KT; Lo CM; Ho JW; Sun BS; Sun CK; Lee TK; Poon RT; Fan ST
    Liver Transpl; 2007 Dec; 13(12):1669-77. PubMed ID: 18044786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.